FII Holdings

ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE1084.75-9.25 (-0.85 %)
PREV CLOSE ( ) 1094.00
OPEN PRICE ( ) 1094.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7964
TODAY'S LOW / HIGH ( )1076.05 1119.20
52 WK LOW / HIGH ( )385.05 1358.8
NSE1084.35-8.05 (-0.74 %)
PREV CLOSE( ) 1092.40
OPEN PRICE ( ) 1102.40
BID PRICE (QTY) 1084.35 (79)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 63987
TODAY'S LOW / HIGH( ) 1076.40 1117.50
52 WK LOW / HIGH ( )380.1 1359.95
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.